Compare JXN & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JXN | PODD |
|---|---|---|
| Founded | 1961 | 2000 |
| Country | United States | United States |
| Employees | 3890 | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.2B |
| IPO Year | 2020 | 2007 |
| Metric | JXN | PODD |
|---|---|---|
| Price | $130.48 | $135.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 21 |
| Target Price | $112.40 | ★ $341.48 |
| AVG Volume (30 Days) | 663.0K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.98 | 2.67 |
| Revenue | ★ $6,683,000,000.00 | $2,708,100,000.00 |
| Revenue This Year | $15.15 | $24.55 |
| Revenue Next Year | $3.44 | $19.18 |
| P/E Ratio | ★ $43.53 | $51.12 |
| Revenue Growth | ★ 104.31 | 30.73 |
| 52 Week Low | $89.67 | $126.40 |
| 52 Week High | $140.90 | $354.88 |
| Indicator | JXN | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 40.22 |
| Support Level | $128.97 | $131.24 |
| Resistance Level | $138.66 | $143.45 |
| Average True Range (ATR) | 4.26 | 4.42 |
| MACD | -1.31 | 0.08 |
| Stochastic Oscillator | 36.41 | 28.39 |
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.